CAP Median Bid Prices, Physician Indifference Likely Contributed To Vendors Spurning Contracts
This article was originally published in The Pink Sheet Daily
Executive Summary
BioScrip will be the only provider of Medicare Part B-covered drugs through the competitive acquisition program for three years.